Depression in Women: Diagnostic and Treatment Considerations

American Family Physician,  July, 1999  by Subhash C. Bhatia,  Shashi K. Bhatia

• E-mail
• Print
• Link

The authors thank William Burke, M.D., of the University of Nebraska and Creighton University, for his review of the manuscript.

The authors of this article provide continuing medical education with financial support from Abbott Laboratories, Bristol-Myers Squibb Company,Glaxo Wellcome Inc. and Eli Lilly and Company.

REFERENCES

1. Weissman MM, Olfson M. Depression in women: implications for health care research. Science 1995;269:799-801.

2. Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997; 58(suppl 15):12-8.

3. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-16.

4. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997;154:1641-7.

5. American College of Obstetrics and Gynecology. Depression in women: ACOG technical bulletin number 182-July 1993. Int J Gynecol Obstet 1993; 43:203-11.

6. Slap GB. Oral contraceptives and depression: impact, prevalence, and course. J Adolesc Health 1981;2:53-64.

7. Pajer K. New strategies in the treatment of depression in women. J Clin Psychiatry 1995;56(suppl 2):30-7.

8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994.

9. Leibenluft E, Hardin TA, Rosenthal NE. Gender differences in seasonal affective disorder. Depression 1995;3:13-9.

10. Hirschfeld RM, Russell JM. Assessment and treatment of suicidal patients. N Engl J Med 1997;337: 910-5.

11. Depression in primary care: detection, diagnosis, and treatment. Rockville, Md.: U.S. Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993; AHCPR publication no. 93-0552.

12. Moscicki EK. Gender differences in completed and attempted suicides. Ann Epidemiol 1994;4:152-8.

13. McGrath E, ed. Women and depression: risk factors and treatment issues. Washington, D.C: American Psychological Association, 1990.

14. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-95.

15. Rubinow DR. The premenstrual syndrome. New views. JAMA 1992;268:1908-12.

16. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski T. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990;20:129-34.

17. Pearlstein T. Nonpharmacologic treatment of premenstrual syndrome. Psychiatr Ann 1996;26:590-4.

18. Gelenberg AJ. Treating PMS. Biol Ther Psychiatry 1997;20:1.

19. Yonkers KA, Brown WA. Pharmacologic treatments for premenstrual dysphoric disorder. Psychiatr Ann 1996;26:586-9.

20. Schmidt PJ, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1993;50:467-73.